Delays in Core Laboratory Testing, Monday, January 13th, 2020

Due to an unexpected informatics issue, some clinical chemistry assays in the core clinical laboratory will be delayed. Core laboratory staff is working with vendor to resolve this issue. We expect to have most available by late tonight. Some assays may still be unavailable tomorrow. The following assays are affected:

Alpha 1 Antitrypsin [LAB927]
Amikacin drug level [LAB555]
Angiotensin-1 converting enzyme [LAB563]
Bile Acids, Total [LAB2713]
Buprenorphine, Urine Screen [LAB8779]
C3 Complement [LAB152]
C4 Complement [LAB151[
Cardiac CRP [LAB150]
Cystatin C [LAB2967]
Kappa/lambda quant free light chain ratio, blood [LAB7454]
Carbamazepine drug level [LAB22]
Ceruloplasmin [LAB582]
Ethylene glycol, rapid assay [LAB7453]
Everolimus drug level [LAB7456]
Haptoglobin [LAB89]
Homocysteine [LAB93]
IgA [LAB73]
IgG [LAB71]
IgM [LAB72]
Keppra (levetiracetam) drug level [LAB477]
Lamotrigine (Lamictal) drug level (LAB475]
Lidocaine drug level [LAB641]
Methotrexate drug level [LAB481]
Myoglobin [LAB105]
Nicotine metabolite, rapid screen [LAB8071]
Pentobarbital drug level [LAB656]
Phenobarbital drug level [LAB30]
Phenytoin free drug level [LAB32]
Phenytoin drug level [LAB31]
Rheumatoid factor [LAB206]
Theophylline drug level [LAB35]
Tobramycin drug level [LAB36]
Urine Neutrophil Gelatinase-Associated Lipocalin [LAB8693]
Valproic acid drug level [LAB25]
Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380, matthew-krasowski@uiowa.edu).